Sartorius Stedim Biotech ...

PNK: SDMHF · Real-Time Price · USD
216.65
-3.35 (-1.52%)
At close: May 30, 2025, 3:33 PM

Sartorius Stedim Biotech S.A. Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.86B 2.78B 2.74B 2.75B 2.72B 2.78B 2.96B 3.17B 3.36B 3.49B 3.38B 3.26B 3.09B 2.89B 2.64B 2.39B 2.14B
Cost of Revenue
1.6B 1.57B 1.59B 1.6B 1.55B 1.54B 1.51B 1.54B 1.6B 1.66B 1.61B 1.54B 1.44B 1.33B 1.22B 1.11B 1.01B
Gross Profit
1.25B 1.21B 1.14B 1.15B 1.17B 1.23B 1.45B 1.63B 1.75B 1.83B 1.77B 1.72B 1.66B 1.55B 1.42B 1.28B 1.13B
Operating Income
434.5M 406.4M 342.4M 348.5M 421.4M 477.2M 647.8M 860.4M 969.2M 1.15B 930.42M 874.62M 799.92M 657.32M 785.35M 701.95M 589.25M
Interest Income
31.5M 27.1M 65.5M 62.9M 123M 105.2M 88.2M 123.3M 87.6M 159.8M 159.8M 128.6M 94.3M 15.5M 15.5M 16.1M 14.8M
Pretax Income
257.2M 218.8M 236M 236M 329.5M 401.1M 578.9M 816.9M 941.2M 1.13B 958.32M 894.32M 813.92M 647.02M 727.43M 660.33M 552.63M
Net Income
204.3M 174.7M 168.9M 169.1M 254.6M 309.7M 456.6M 631.5M 713.2M 872.3M 693.81M 642.01M 575.71M 431.31M 537.35M 488.35M 406.25M
Selling & General & Admin
654.5M 648.7M 645.3M 639.3M 624.2M 616.3M 598M 602.9M 603.3M 601.1M 604.36M 576.66M 563.66M 531.76M 477.34M 449.74M 416.44M
Research & Development
148.8M 144.1M 144M 135.1M 128.7M 129.6M 131.1M 131.6M 134.5M 132.4M 125.09M 123.29M 119.19M 110.59M 103.25M 98.15M 89.15M
Other Expenses
51.8M 42.5M 46.9M 35.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
819.9M 800.1M 801M 800.4M 818.9M 844.5M 800.1M 802.6M 779.2M 751.6M 756.62M 730.12M 708.92M 670.02M 620.98M 571.08M 532.78M
Interest Expense
164.1M 100.8M 153.6M 157.1M 132.2M 152.6M 88.6M 63.2M 47.7M 38.3M 38.3M 46.5M 52.2M 76.5M 76.5M 60.2M 55.2M
Selling & Marketing Expenses
485.7M 480M 473.9M 465.7M 455M 449.2M 446.7M 452.2M 452.1M 446.5M 448.15M 434.35M 424.55M 405.65M 366.65M 340.35M 315.25M
Cost & Expenses
2.42B 2.37B 2.39B 2.4B 2.37B 2.39B 2.31B 2.34B 2.38B 2.41B 2.37B 2.27B 2.15B 2B 1.84B 1.68B 1.54B
Income Tax Expense
50.6M 40.6M 62.9M 62.9M 71.9M 89M 118.3M 177.6M 220.3M 250.6M 261.31M 255.91M 245.71M 232.41M 204.61M 180.71M 150.01M
Shares Outstanding (Basic)
97.27M 97.32M 97.32M 97.32M 96.72M 92.16M 92.17M 92.17M 92.17M 92.17M 92.02M 92.18M 92.18M 92.18M 92.18M 92.18M 92.5M
Shares Outstanding (Diluted)
97.27M 97.32M 97.32M 97.32M 96.72M 92.16M 92.17M 92.17M 92.17M 92.17M 92.12M 92.19M 92.22M 92.18M 92.42M 92.24M 92.5M
EPS (Basic)
2.10 1.80 1.76 1.78 2.73 3.36 4.96 6.86 7.75 9.47 7.53 6.96 6.24 4.67 5.58 5.05 4.16
EPS (Diluted)
2.10 1.80 1.76 1.78 2.73 3.36 4.96 6.86 7.75 9.47 7.53 6.96 6.24 4.67 5.58 5.05 4.16
EBITDA
717.3M 644.8M 671.8M 675.1M 659.5M 693.5M 806.1M 984.9M 1.12B 1.29B 1.05B 992.17M 945.67M 794.77M 918.33M 825.13M 700.63M
EBIT
421.3M 352.6M 397.7M 401.1M 469.7M 528.7M 647.7M 861.5M 933.1M 1.03B 806.82M 746.02M 709.62M 655.32M 783.35M 701.55M 586.25M
Depreciation & Amortization
308.7M 301.7M 283.6M 283.5M 259.4M 237.6M 231.2M 197.3M 189.6M 181.7M 161.46M 158.66M 149.86M 140.66M 136.18M 121.88M 111.38M